Ceruletide Ammonium acetate
Code | Size | Price |
---|
TAR-T14932L-25mg | 25mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14932L-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14932L-1mg | 1mg | £272.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14932L-5mg | 5mg | £482.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14932L-10mg | 10mg | £667.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant.
CAS:
T14932L
Formula:
C60H77N13O23S2
Molecular Weight:
1412.46
Pathway:
GPCR/G Protein
Purity:
0.98
SMILES:
[H][C@]([C@H](O)C)(C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC1=CC=CC=C1)=O)CC(O)=O)=O)CCSC)=O)CC2=CNC3=CC=CC=C23)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]4CCC(N4)=O)=O)CCC(N)=O)=O)CC(O)=O)=O)CC5=CC=C(C=C5)OS(O)(=O)=O)=O.CC(O)=O
Target:
cholecystokinin
References
1. M E Vincent, et al. Pharmacotherapy. Jul-Aug 1982;2(4):223-34.[2] M R Zarrindast, et al. Pharmacol Toxicol. 1995 Dec;77(6):360-4.[3] Joanna Bonior, et al. Int J Mol Sci. 2017 May 2;18(5):929.
2. Smith GP, et al. Ceruletide acts in the abdomen, not in the brain, to produce satiety. Peptides. 1984 Nov-Dec;5(6):1149-57.
3. Mattes JA, et al. Ceruletide for schizophrenia: a double-blind study. Biol Psychiatry. 1985 May;20(5):533-8. doi: 10.1016/0006-3223(85)90024-PMID: 2859054.